Cystic fibrosis - mannitol dry powder for inhalation: review consultation - May 2015 information
History
Documents created during the development process.
Background information
-
-
Cystic fibrosis - mannitol dry powder for inhalation: appendix A - matrix of stakeholders
-
-
Cystic fibrosis - mannitol dry powder for inhalation: appendix B - GE proposal paper May 2015
-
-
TA266 Cystic fibrosis - mannitol dry powder for inhalation: press release information
Cystic fibrosis - mannitol: Equality Impact Assessment - Guidance development
-
Cystic fibrosis - mannitol: Equality Impact Assessment - Guidance development
-
Cystic fibrosis - mannitol: Equality Impact Assessment - Guidance development (PDF 19 KB)
Cystic fibrosis - mannitol: final appraisal determinaton
-
Cystic fibrosis - mannitol: final appraisal determinaton information
-
Cystic fibrosis - mannitol: final appraisal determinaton
-
Cystic fibrosis - mannitol: final appraisal determinaton (PDF 350 KB)
-
Cystic fibrosis - mannitol: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)
-
-
Cystic fibrosis - mannitol: consultee and commentator comments on the ACD
-
Cystic fibrosis - mannitol: Pharmaxis
-
-
Cystic fibrosis - mannitol: Cystic Fibrosis Trust
-
Cystic fibrosis - mannitol: Cystic Fibrosis Trust (PDF 59 KB)
-
Cystic fibrosis - mannitol: British Thoracic Society (the Royal College of Physicians supports these comments)
-
-
Cystic fibrosis - mannitol: Royal College of Nurses
-
Cystic fibrosis - mannitol: Royal College of Nurses (PDF 19 KB)
-
Cystic fibrosis - mannitol: Department of Health
-
Cystic fibrosis - mannitol: Department of Health (PDF 6.5 KB)
-
Cystic fibrosis - mannitol: Sandwell PCT
-
-
Cystic fibrosis - mannitol: Commissioning Support Appraisals Service
-
Cystic fibrosis - mannitol: Commissioning Support Appraisals Service (PDF 97 KB)
-
Cystic fibrosis - mannitol: Bilton
-
-
Cystic fibrosis - mannitol: comments on the ACD received from the public through the NICE website
-
-
Cystic fibrosis - mannitol: addendum to Evidence Review Group's Report following Pharmaxis' new evidence submission of 3rd July 2012
-
Cystic fibrosis - mannitol: appraisal consultation
-
Cystic fibrosis - mannitol: appraisal consultation
-
Cystic fibrosis - mannitol: appraisal consultation document information
-
Cystic fibrosis - mannitol: evaluation report
-
Cystic fibrosis - mannitol: pre-meeting briefing
-
Cystic fibrosis - mannitol: pre-meeting briefing (PDF 209 KB)
-
Cystic fibrosis - mannitol: Evidence Review Group report
-
Cystic fibrosis - mannitol: Evidence Review Group report (PDF 853 KB)
-
Cystic fibrosis - mannitol: Evidence Review Group report - factual accuracy check
-
Cystic fibrosis - mannitol: Evidence Review Group report - factual accuracy check (PDF 38 KB)
-
Cystic fibrosis - mannitol: Pharmaxis
-
-
Cystic fibrosis - mannitol: clarification
-
Cystic fibrosis - mannitol: NICE clarification letter
-
Cystic fibrosis - mannitol: NICE clarification letter (PDF 38 KB)
-
Cystic fibrosis - mannitol: manufacturer response to the NICE clarification letter
-
Cystic fibrosis - mannitol: manufacturer response to the NICE clarification letter (PDF 435 KB)
-
Cystic fibrosis - mannitol: patient group, professional group and NHS organisation submission statements
-
Cystic fibrosis - mannitol: British Thoracic Society
-
Cystic fibrosis - mannitol: British Thoracic Society (PDF 24 KB)
-
Cystic fibrosis - mannitol: Royal College of Nursing
-
Cystic fibrosis - mannitol: Royal College of Nursing (PDF 31 KB)
-
Cystic fibrosis - mannitol: Royal College of Paediatrics and Child Health
-
Cystic fibrosis - mannitol: Royal College of Paediatrics and Child Health (PDF 26 KB)
-
Cystic fibrosis - mannitol: Sandwell Primary Care Trust
-
Cystic fibrosis - mannitol: Sandwell Primary Care Trust (PDF 53 KB)
-
Cystic fibrosis - mannitol: expert written personal statements
-
Cystic fibrosis - mannitol: Agent
-
-
Cystic fibrosis - mannitol: Bilton
-
-
Cystic fibrosis - mannitol: Lake
-
-
Cystic fibrosis - mannitol: Macherianakis
-
Mannitol - cystic fibrosis: final scope
-
Mannitol - cystic fibrosis: final scope
-
Mannitol - cystic fibrosis: final matrix of consultees and commentators
-
Mannitol - cystic fibrosis: final matrix of consultees and commentators
-
Mannitol - cystic fibrosis: final matrix of consultees and commentators (PDF 30 KB)
Mannitol - cystic fibrosis: Institute's response to consultee and commentator comments on the draft scope
-
Mannitol - cystic fibrosis: Institute's response to consultee and commentator comments on the draft scope
-
Mannitol - cystic fibrosis: Institute's response to consultee and commentator comments on the provisional matrix
-
Mannitol - cystic fibrosis: Institute's response to consultee and commentator comments on the provisional matrix
-
Mannitol - cystic fibrosis: draft scope
-
Mannitol - cystic fibrosis: draft scope
-
Mannitol - cystic fibrosis: provisional matrix
-
Mannitol - cystic fibrosis: provisional matrix
-